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Background: Ductular reactions (DRs) are well documented in many acute and chronic liver disease.The DRs are
thought to be the transit amplifying cells deriving from activation of the stem/progenitor cell compartments of the
liver. The aim of this study was to examine the presence of proliferative index of DR (PI-DR) and HPC markers’
expression in HCCs after curative hepatectomy, as well as their relationship with clinicopathological features and
prognosis.
Results: Tissue microarray with peritumoral and intratumoral tissue samples of 120 HCCs after hepatectomy was
analysed for peritumoral expression of proliferating cell nuclear antigen for PI-DR. Peritumoral and intratumoral
expression status of HPC markers including EpCAM, OV6, CD133 and c-kit were also examined by immunohistochemistry.
TMA analysis of HCCs revealed that peritumoral PI-DR strongly correlated with the degree of inflammation and fibrosis.
The peritumoral PI-DR positively correlated with peritumoral HPC markers EpCAM, OV6, CD133 and c-kit expression.
Moreover, there were highly significant correlations between peritumoral PI-DR and intratumoral HPC markers EpCAM,
OV6, CD133 and c-kit expression. Further, multivariate analysis showed that peritumoral PI-DR was the independent
prognostic factor for overall survival (HR; 3.316, P < 0.001), and peritumoral PI-DR had a better power to predict
disease-free survival (HR; 2.618, P < 0.001).
Conclusions: Peritumoral PI-DR, as a valid surrogate for peritumoral and intratumoral expression of HPC markers,
could be served as a potential prognostic marker for recurrence and survival in HCC after hepatectomy.
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Hepatocellular carcinoma (HCC) is one of the main con-
cerns in global health care which is difficult to cure be-
cause of recurrence after resection [1,2]. Most research
has been focused on the discovery of specific markers
useful for HCC diagnosis and prognostic prediction to
provide scientific guidance to clinical management [3,4].
Recently, a number of investigations have demonstrated
that the involvement of a ductular reaction (DR), which
is a reactive lesion at the portal tract interface compri-
sing increased bile ductules with an accompanying* Correspondence: weilixin_smmu@163.com
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unless otherwise stated.complex of stromal and inflammatory cells, has been im-
plicated in the pathogenesis of progressive fibrosis, regen-
eration and hepato-carcinogenesis in chronic liver disease
[5,6]. The main epithelial component of DR are reactive
ductule cells (RDCs) with biliary/HPC phenotype ar-
ranged in an irregularly shaped structure residing along
parenchymal-stromal boundaries. The RDCs are patho-
logical, proliferative, biliary epithelial cell-like cells formed
during repair process after liver injury, and are able to se-
crete various cytokines and chemokines, which interact
with microenvironment [7]. In previous studies, we have
reported that peritumoral DR in a necroinflammatory
microenvironment was a poor prognostic factor for HCC
after resection [8]. However, the role of the proliferation
status of DR remains elusive in HCC.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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chronic liver diseases, but it seems especially important
in hepatic stem and progenitor cells in liver regeneration
mechanisms underlying hepatic fibrosis, and hepatobili-
ary carcinogenesis. Although not well described, how-
ever, when there is either massive liver injury or chronic
liver damage that compromise the proliferative capacity
of hepatocytes, progenitor cells within the Canal of He-
ring start to proliferate, giving rise to what is known as
ductular reaction [9,10]. The hepatic progenitor cells
(HPCs) have been identified in the human liver as bipo-
tential cells capable of proliferation and differentiation
into both hepatocellular and biliary cell lineages [11,12].
HPCs are reportedly recognized as cells smaller than
normal hepatocytes, and present as a single cell or
strings of a few such cells in periportal or periseptal re-
gions of regenerative nodules or hepatic lobules. HPCs
express biliary markers (such as OV6 and EpCAM), and
a subset of these cells expresses hematopoietic markers
(such as the receptor for stem cell factor c-kit [KIT] and
prominin-1 [PROM1]/CD133) [13-16]. In additon,
HCCs expressing HPC markers are likely to have signifi-
cantly more negative prognosis and a higher recurrence
after surgical resection and liver transplantation [17,18].
To the best of our knowledge, the significance of the
proliferative DR (PI-DR) and the correlation between PI-
DR and the expression of HPC markers in terms of
HCC prognosis has not been studied in detail.
Therefore, we performed a clinicopathological study
on 120 cases who had undergone hepatectomy for histo-
logically proven HCC, using the tissue microarray con-
taining paired peritumoral and intratumoral liver
specimens, we quantified the proliferative index of DR
(PI-DR) in the peritumoral tissue. In addition, immuno-
histochemical detection of peritumoral and intratumoral
HPC markers were performed to investigate the rela-
tionship between PI-DR and HPCs in detail. Moreover,
we further explore the role of PI-DR in the HCC prog-




The clinical and histological data are summarized in
Table 1. Among the 120 subjects with pathological spec-
imens available for assessment, 108 (90.0%) were male.
This table also details the distribution of subjects within
each grade of inflammation and stage of fibrosis. At the
time of the last follow-up, 111 patients had tumor recur-
rence and 76 patients had died, and all patients died
with a record of tumor recurrence. Among patients
undergoing curative resections (n =120) the 1-, 3-, and
5-year overall survival (OS) rates were 92.3%, 46.4%, and
32.6%, respectively, and the 1-, 3-, and 5-year disease-free survival (DFS) rates were 70.7%, 14.7%, and 9.6%,
respectively.
Peritumoral proliferative ductular reaction (PI-DR) is
present in HCC and correlates with the degree of
inflammation and fibrosis
As reported, the ductular reaction (DR) was positive uni-
formly and strongly for cytokeratin 7 staining [12]. In
peritumoral K7 staining sections of the entire tissue
microarray group, DR was frequently found in the fi-
brous septa and the enlarged periportal areas in HCC
patients (Figure 1A). Further, In terms of PI-DR, the
proliferating cell nuclear antigen (PCNA) was labeled for
the proliferation status of DR (Figure 1B). 37 of 120 pa-
tients (30.8%) had PI-DR ≥50%.
Previous studies have shown that DRs correlate with
the degree of inflammation and fibrosis in the course of
many chronic human liver diseases [9,10]. Thus, we
evaluated the liver necroinflammation and fibrosis and
their association with PI-DR. Consistent with prior stud-
ies, we observed PI-DR correlated with hepatic necroin-
flammation grade (r = 0.614, P < 0.001, Figure 1C).
Correlations were also found between PI-DR and fibrosis
stage (r = 0.527, P < 0.001, Figure 1D).
Expression of hepatic progenitor cell markers in
peritumoral tissue of HCC patients and clinicopathologic
correlations:relationship with peritumoral PI-DR
Several markers, including EpCAM, OV6, CD133 and c-
kit, which are expressed as markers for hepatic progeni-
tor cells (HPCs), have been considered to be the origin
of HCCs [19]. However, the link between PI-DR and ex-
pression of HPC markers has not been fully elucidated.
We firstly conducted an immunohistochemical analysis
of four HPC markers (EpCAM, OV6, CD133 and c-kit)
in the peritumoral tissue sections of the entire group,
the high EpCAM, OV6, CD133 and c-kit expression was
seen in 40 of 120 (33.3%), 34 of 120 (28.3%), 33 of 120
(27.5%), and 39 of 120 (32.5%) cases, respectively
(Table 2). EpCAM expression was seen in the membrane
and cytoplasm of cholangiocytes of all branches of the
biliary tree, including canals of Hering, ductules, and
small and large bile ducts. The ductular OV-6-positive
cells with a more transitional morphology, represented
small numbers of individual oval-like cells adjacent to
ducts in marginal regions. CD133-positive cells were
mostly accumulated as patches with granular appearance
in the cytoplasm of a few scattered hepatocytes. C-kit
positive cells were diffused in the parenchyma in HCCs
(Figure 2A).
HCCs were grouped according to the expression sta-
tus of peritumoral HPC markers, and clinicopathologi-
cal parameters were further analyzed. As shown in
Table 2, patients with a high peritumoral EpCAM and
Table 1 Demographic and baseline characteristics of 120 patients with hepatocellular carcinoma
Factors Value Percent
Demographic characteristics
Age 50.1 ± 11.9
Gender (male/female) 108/12 90.0/10.0
Tumor characteristics
Maximum tumor diameter 6.9 ± 4.2
Tumor encapsulation 33 27.5
Tumor number (multiple)* 15 12.5
Microvascular invasion 65 54.2
Major vascular invasion 6 5.0
Edmondson grade
Low (I/II) 90 75.0




Histology of chronic liver disease
Necroinflammation grade (score)
No (0) 0 0.0
Minimal (1–4) 6 5.0
Mild (5–8) 38 31.7
Moderate (9–12) 57 47.5






AFP (ng/mL) 351.0 ± 414.1 (1.7-1000.0)
CEA (ng/mL) 4.3 ± 7.1 (0.0-58.2)
CA19-9 (U/mL) 15.8 ± 14.4 (0.0-120.8)
ALT (U/L) 54.6 ± 37.2 (9.8-234.9)
AST (IU/L) 39.5 ± 19.4 (2.0-108.3)
Abbreviations: AFP alpha-fetoprotein; CEA carcinoembryonic antigen; CA19-9 carbohydrate antigen 19–9; ALT alanine aminotransferase; AST aspartate aminotransferase;
TNM tumor-node-metastasis.
*Multifocal tumors diagnosed by preoperative image finding.
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TNM stage, high Edmondson grade in patients with
the high peritumoral OV6 expression, and high peritu-
moral c-kit expression patients demonstrated more
cirrhosis.
Next, we further identify the correlation between PI-DR
and the peritumoral HPC markers’ expression (IOD).
PI-DR had a positive correlation with EpCAM (r = 0.441,
P < 0.001), OV6 (r = 0.342, P < 0.001), CD133 (r = 0.408,
P < 0.001) and c-kit expression (r = 0.291, P = 0.001)
(Figure 2B) in peritumoral tissue of the entire group.These findings support the concept that proliferative DR
in peritumoral environment may contribute to activation
of progenitor cells and related carcinogenesis.
Peritumoral PI-DR as a valid surrogate for intratumoral
expression of HPC markers
To assess if the intratumoral expression of HPC markers
were correlated with PI-DR in our study, we further per-
formed an IHC analysis of four HPC markers (EpCAM,
OV6, CD133 and c-kit) in the intratumoral tissue sec-
tions of the entire group as shown in Figure 3A, the high
Figure 1 PCNA labeling index of ductular reaction (PI-DR) positively correlated with the necroinflammation grade and fibrosis stage.
(A) The K7 immunostaining ductular reaction seen with examples in peritumoral tissue of hepatocellular carcinoma (sacle bar = 100 μm).
Increased numbers of ductular reactions (≥50%) are noted at the edge of the portal tract containing a lymphoid aggregate (left), whereas
continuous ductular reactions (<50%) are present along the edge of an enlarged portal tract (right). (B) Light micrograph of area displaying PCNA
staining for DR represents a low level of proliferation activity (upper right) and a high level of proliferation activity (lower right), as corresponding
with serious K7 staining of DR (sacle bar = 100 μm). (C) A split scattergram with fitting line shows peritumoral PI-DR correlates with necroinflammation
grade in peritumoral tissue. (D) The peritumoral PI-DR is significantly correlated with fibrosis stage. Spearman correlation analysis provides correlation
coefficient (r) and P-value.
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Male 35 73 0.747 30 78 0.946 30 78 1.000 37 71 0.363
Female 5 7 4 8 3 9 2 10
Age
≤50 21 42 1.000 16 47 0.453 19 44 0.493 20 43 0.853
>50 19 38 18 39 14 43 19 38
AFP
≤400 25 56 0..408 22 59 0.681 23 58 0.752 24 57 0.333
>400 15 24 12 27 10 29 15 24
Cirrhosis
Absence 20 51 0.149 19 52 0.645 17 54 0.294 17 54 0.016*
Presence 20 29 15 34 16 33 22 27
Satellite lesion
Absence 36 69 0.770 28 77 0.284 29 76 1.000 35 70 0.606
Presence 4 11 6 9 4 11 4 11
Tumor size (cm)
≤5cm 15 37 0.362 15 37 0.913 16 36 0.483 18 34 0.665
>5cm 25 43 19 49 17 51 21 47
Tumor encapsulation
Absence 26 61 0.193 26 61 0.540 23 64 0.672 27 60 0.578
Presence 14 19 8 25 10 23 12 21
Microvascular invasion
Absence 17 38 0.604 17 38 0.565 18 37 0.238 22 33 0.107
Presence 23 42 17 48 15 50 17 48
Major vascular
invasion
Absence 39 75 0.657 33 81 0.853 29 85 0.083 38 76 0.687
Presence 1 5 1 5 4 2 1 5
Edmondson grade
Low (I/II) 27 63 0.180 21 69 0.035* 23 67 0.409 28 62 0.574
High (III/IV) 13 17 13 17 10 20 11 19
TNM stage
I/II 25 67 0.009* 23 69 0.142 16 76 <0.001* 29 63 0.678
III 15 13 11 17 17 11 10 18
*p <0 .05 was considered statistically significant.
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kit was seen in 39 of 120 (32.5%), 26 of 120 (21.7%), 29
of 120 (24.2%), and 34 of 120 (28.3%) cases, respectively
(Table 3).
HCCs were grouped according to intratumoral HPC
expression, and clinicopathological features were com-
pared as shown in the Table 3. High intratumoralEpCAM was significantly associated with more major
vascular invasion (P = 0.023), high AFP (P < 0.001) and
high Edmondson grade (P = 0.005), High intratumoral
OV6 expression of the entire group demonstrated more
cirrhosis (P = 0.015). High intratumoral c-kit expression
was significantly more likely to occur in high Edmondson
grade (P = 0.010).
Figure 2 (See legend on next page.)
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Figure 2 The peritumoral PI-DR positively correlates with the peritumoral expression of HPC markers. (A) Photographs of immunostaining
of hepatic progenitor cell markers in peritumoral sections of tissue microarrays were taken for analyses (sacle bar = 100 μm). High and low density of
EpCAM, OV6, CD133 and c-kit expression in peritumoral sections. (B) Scatterplot with fitting line shows peritumoral PI-DR positively correlates with
peritumoral EpCAM, OV-6, CD133 and c-kit expression measured by IOD. Pearson correlation analysis provides correlation coefficient (r) and P-value.
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intratumoral HPC markers’ expression (IOD). PI-DR had
a positive correlation with intratumoral EpCAM (r =
0.328, P < 0.001, OV6 (r = 0.466, P < 0.001), CD133 (r =
0.356, P < 0.001) and c-kit expression (r = 0.398, P < 0.001)
(Figure 3B) in the entire group. Thus, together these re-
sults suggest that PI-DR could be used as a valid surrogate
for intratumoral expression of HPC markers.The association of peritumoral high PI-DR in HCC with
poor disease-free survival
The survival of the selected HCC patients was analyzed
with Kaplan-Meier survival analysis. Patients with high
PI-DR (≥50%) were likely to be with significantly poor
OS and DFS. The median (95% CI) overall survival time
was 25.3 (21.7-28.8) and 48.8 (31.3-66.3) months re-
spectively for patients with high PI-DR (≥50%) and low
PI-DR (<50%) in HCC (P < 0.001, Figure 4A). The me-
dian (95% CI) disease-free survival time was 10.1 (7.0 -
13.2) and 21.2 (18.4 - 24.1) months respectively for pa-
tients with high PI-DR (≥50%) and low PI-DR (<50%) in
HCC (P < 0.001, Figure 4B).Univariate and multivariate analyses of prognostic
variables in HCC patients
In univariate analysis, PI-DR (≥50% vs < 50%), K7-DR
(≥50% vs < 50%), TNM stage (I/II vs. III), macrovascular
invasion (presence vs. absence) and intratumoral EpCAM
Expression (High vs. Low) showed a significant association
with poor overall survival (P < 0.001, P = 0.045, P = 0.030,
P = 0.014 and P = 0.017 respectively, Table 4). Univariable
analysis also revealed that PI-DR (P < 0.001), TNM stage
(I/II vs. III) (P = 0.001), Edmondson grade (I/II vs. III/IV)
(P = 0.043), peritumoral EpCAM expression (High vs.
Low) (P = 0.003), peritumoral CD133 expression (High vs.
Low) (P < 0.001), intratumoral OV6 expression (High vs.
Low) (P = 0.034) were independent prognostic factors for
DFS after resection (Table 4).
Factors showing significance by univariate analysis
were adopted when multivariate Cox proportional haz-
ards analysis was performed (Table 4). PI-DR (HR: 3.316,
95% CI: 1.961 - 5.610, P < 0.001), K7-DR (HR: 1.863,
95% CI: 1.008-3.443, P = 0.047) were independent prog-
nostic factors for overall survival. Moreover, PI-DR (HR:
2.618, 95% CI: 1.701 - 4.029, P < 0.001) and TNM stage
(HR: 1.817, 95% CI: 1.135 - 2.909, P = 0.013) were also
independent predictors for disease-free survival.Discussion
The main findings of our study are that in a cohort of
patients with HCC (1) the peritumoral proliferative
index of DR (PI-DR) stained with PCNA is observed
within the HCCs and the PI-DR correlates closely with
the necroinflammation grade and fribrosis stage. (2) The
PI-DR correlates strongly with the expression of peritu-
moral and intratumoral HPC markers in HCC patients.
(3) PI-DR is the independent risk factor for both DFS
and OS in HCCs.
It is well known that the important consequences of the
ductular reaction are inflammatory infiltration, rich in
neutrophil inflitration (cholangiolitis), periportal fibrosis
and neovascularization [20]. The extensive analysis sup-
ported that the DRs correlated closely with severity of fi-
brosis across a range of liver pathologies including chronic
hepatitis C, alcoholic and non-alcoholic steatohepatitis,
and fibrosing cholestatic hepatitis [12]. In our study, that
is also evidenced by high levels of proliferation rate within
DRs strongly correlating with necroinflammation and fi-
brosis in HCC patients. Our study does not prove that the
proliferative ductular reaction directly promote necroin-
flammation and fibrosis, or that the reaction is simply a
by-product of necroinflammation and fibrosis. Clouston
[9] and colleagues found that the presence of a fine duct-
ular reaction in some patients without portal fibrosis, may
suggest that the ductular reaction itself may be important
in the development of fibrosis.
In normal liver undergoing partial hepatectomy or
acute injury, hepatocyte-mediated regeneration predomi-
nates. In chronic and severe injury, however, ductular re-
actions (DRs) of activated biliary epithelial cells which
contain hepatic progenitor cells (HPCs) appear in the
periportal regions. In our study, we studied the prolifera-
tive state of ductular reaction, with PCNA as a prolife-
ration marker, to test the hypothesis that whether the
proliferative ductular reaction (PI-DR) correlated with the
expression of peritumoral and intratumoral HPC markers.
We identified PI-DR had positive correlations with
EpCAM, OV6, CD133 and c-kit expression in both peritu-
moral and intratumoral tissue of the entire group. Our
data indicated that proliferative ductular reaction could
serve as a valid surrogate for peritumoral and intratumoral
expression of HPC markers. Consistent with our findings,
Cai et al. [21] have found that proliferative ductular reac-
tion is related to HPC activation in patients with com-
bined hepatocellular-cholangiocarcinoma. Lennerz and
colleagues [22] suggested marked alterations in cellular
Figure 3 The peritumoral PI-DR positively correlates with the intratumoral HPC markers expression. (A) Photographs of immunostaining
of hepatic progenitor cell markers in intratumoral sections of tissue microarrays were taken for analyses (sacle bar =100 μm) . High and low
density of EpCAM, OV6, CD133 and c-kit expression in intratumoral sections. (B) Scatterplot with fitting line shows peritumoral PI-DR positively
correlates with the intratumoral EpCAM, OV-6, CD133 and c-kit expression measured by IOD. Pearson correlation analysis provides correlation
coefficient (r) and P-value (right).
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Male 34 74 0.697 21 87 0.161 26 82 1.000 32 76 0.543
Female 5 7 5 7 3 9 2 10
Age
≤60 19 44 0.565 19 62 0.493 13 50 0.342 19 44 0.641
>60 20 37 7 32 16 41 15 42
AFP
≤400 17 64 <0.001* 19 62 0.493 20 61 0.847 23 58 0.983
>400 22 17 7 32 9 30 11 28
Cirrhosis
Absence 21 50 0.411 10 61 0.015* 14 57 0.171 17 54 0.199
Presence 18 31 16 33 15 34 17 32
Satellite lesion
Absence 33 72 0.507 22 83 0.867 27 78 0.468 33 72 0.092
Presence 6 9 4 11 2 13 1 14
Tumor size (cm)
≤5cm 15 37 0.455 14 38 0.222 13 39 0.852 12 40 0.264
>5cm 24 44 12 56 16 52 22 46
Tumor encapsulation
Absence 26 61 0.321 18 69 0.673 19 68 0.334 27 60 0.286
Presence 13 20 8 25 10 23 7 26
Microvascular invasion
Absence 15 40 0.261 14 41 0.354 12 43 0.580 17 38 0.565
Presence 24 41 12 53 17 48 17 48
Major vascular
invasion
Absence 34 80 0.023* 25 89 1.000 28 86 1.000 32 82 1.000
Presence 5 1 1 5 1 5 2 4
Edmondson grade
Low (I/II) 23 67 0.005* 17 73 0.201 19 71 0.176 20 70 0.010*
High (III/IV) 16 14 9 21 10 20 14 16
TNM stage
I/II 27 65 0.181 17 75 0.124 20 72 0.260 28 64 0.354
III 12 16 9 19 9 19 6 22
*p <0 .05 was considered statistically significant.
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cible perinodular DR that parallels progressive stages
of intranodular hepatocarcinogenesis. Several studies
have also shown that high levels of proliferation rate
within DRs has been demonstrated in both oval cell-
mediated liver regeneration in an animal model and
human liver disease [23,24]. The other publishedstudies have shown that ductular reaction is frequently
associated with fibrosis and inflammation in chronic
liver disease and may be key factors promoting liver
progenitor cell expansion in alcoholic hepatitis [25].
Delladetsima et al. [26] have reported a periportal
ductular reaction was noted in association with HPC
expansion in HCV.
Figure 4 Cumulative overall and disease-free survival curves of HCC patients with high or low PI-DR. (A) Low PI-DR in peritumoral tissue
was associated with prolonged overall survival. (B) High PI-DR in peritumoral tissue was associated with poor disease-free survival. Low PI-DR:
(<50%); High PI-DR (≥50%).
Table 4 Univariate and multivariate analyses of factors associated with survival and recurrence in hepatocellular
carcinoma group of testing cohort (n = 120)
Factors Overall Survival (OS) Disease-free Survival (DFS)
Univariate Multivare Univariate Multivariate
P HR (95% CI) P P HR (95% CI) P
Characteristic of Age: >50 vs. ≤50 years* 0.719 NA 0.981 NA
Demography, Gender: male vs. female 0.846 NA 0.088 NA
Tumor & Tumor size: >5 vs. ≤5 cm 0.061 NA 0.130 NA
Laboratory Tumor number: multiple vs. single 0.221 NA 0.192 NA
Tests Serum AFP: ≥400 vs. <400 ng/ml 0.285 NA 0.382 NA
Serum CA199≥ 37 vs. < 37 U/ml 0.798 NA 0.236 NA
TNM stage: I/II vs. III 0.030* NS 0.001* 1.817 (1.135-2.909) 0.013*
Edmondson grade: I/II vs. III/IV 0.074 NA 0.043* NS
Macrovascular Invasion: P vs. N 0.014* NS 0.114 NA
Tumor encapsulation: absence vs. presence 0.791 NA 0.311 NA
Histology: Ishak grade >7 vs. ≤ 7 0.058 NA 0.072 NA
Peritumor Ishak stage >5 vs. ≤ 5 0.096 NA 0.120 NA
PI-DR≥ 50% vs. <50% <0.001* 3.316(1.961-5.610) <0.001* <0.001* 2.618(1.701-4.029) <0.001*
K7-DR≥ 50% vs. <50% 0.045* 1.863(1.008-3.443) 0.047* 0.158 NA
EpCAMPeritumor Expression H vs. L* 0.319 NA 0.003* NS
OV6Peritumor Expression H vs. L* 0.191 NA 0.702 NA
C-kitPeritumorExpression H vs. L* 0.721 NA 0.935 NA
CD133Peritumor Expression H vs. L* 0.051 NA <0.001* NS
Histology: Microvascular invasion: P vs. N 0.327 NA 0.595 NA
Tumor: EpCAM Expression H vs. L* 0.017* NS 0.093 NA
OV6 Expression H vs. L* 0.756 NA 0.034* NS
C-kit Expression H vs. L* 0.352 NA 0.127 NA
CD133 Expression H vs. L* 0.394 NA 0.091 NA
P, positive; N, negative; H, High; L, Low; NA, not adopted; NS, not significant;AFP, alpha-fetoprotein; ALT, alanine aminotransferase; CA19-9, carbohydrate antigen
19–9; CI, confidence interval; PI-DR, proliferative index of ductular reaction; DR, ductular reaction; EpCAM, epithelial cell adhesion molecule; HCC, hepatocellular
carcinoma; HR, hazard ratio; K7-DR, Keratin 7 immunoreactive ductular reaction; TNM, tumor-node-metastasis;
*Medians were used for cutoff values.
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histochemical analysis of four HPC markers (EpCAM,
OV6, CD133 and c-kit) in peritumoral tissue microarray,
and compared the various clinicopathologic features ac-
cording to the expression status of each of these
markers. In our study, univariate survival analysis
demonstated that peritumoral EpCAM expression and
peritumoral CD133 expression were independent predic-
tors of disease-free survival. This stands in consistent
with findings reported by Hoshida et al. [27], their group
disclosed that gene expression profiles of HCC failed
to yield a significant association with survival, whereas
surrounding nontumoral profiles correlated with re-
currence. Moreover, in our data the intratumoral
expression of HPC markers’ expression were also stu-
died in the microarray tissue of the HCCs. Univariate
survival analysis also demonstated that intratumoral
EpCAM expression was an independent predictor of
overall survival. Bae et al. [28] have also demonstrated
EpCAM expression occurs at distinct nodular stage
of HCC and could play an important role in HCC
progression.
High incidence of intrahepatic metastasis and recur-
rence after resection suggested that peritumoral environ-
ment is an important but often neglected issue. In our
previous study, Xu et al. [8] have uncovered peritumoral
DR in a necroinflammatory microenvironment correlates
with postoperative prognosis in HCC. Richardson et al.
[10] found that an altered replication pathway in active
nonalcoholic steatohepatitis promotes a periportal DR,
which in turn may provoke progressive periportal fibro-
genesis. The main finding of our study is that the peritu-
moral proliferative state of DR (PI-DR) is correlated with
necroinflammation grade and fribrosis stage, and PI-DR
may be involved in the HPC-derived carcinogenesis in
the progression of HCC. Our finding are in accord with
the following prior published data regarding the prolifer-
ative state of ductular reaction. Cai et al. [21] in our lab
also identified that a “progenitor dominant” regeneration
pattern, which is closely related with intensive transit-
amplifying DR, is associated with the poorest OS and
DFS. Yoon et al. [29] found the cells of ductular reac-
tions showed markedly elevated proliferation rates in pa-
tients with worsening stage of chronic hepatitis B and C.
Importantly in our study, in Cox regression analysis in-
cluding all clinico-pathological covariates for analysis,
peritumoral PI-DR was the independent predictor for
overall and disease-free survival in HCC.
Taken together, our results demonstrated that peritu-
moral PI-DR, strongly correlated with both the peritu-
moral and intratumoral HPC expression, may be
associated with subsequent tumor development. PI-DR
could be a useful marker for prognostic prediction of re-
currence in HCC.Conclusion
In summary, we found that in HCC patients, the peritu-
moral DR with higher PCNA labeling index was prone
to correlate with the degree of necroinflammatory activ-
ity and the stage of fibrosis. We also demonstrated the
peritumoral PI-DR correlated stongly with both the peri-
tumoral and intratumoral expression of HPC markers,
and peritumoral PI-DR predicted reccurrence in HCC
after hepatectomy. These findings suggested that the PI-
DR which strongly correlated with HPC markers could
represent an early stage of carcinogenesis in HCC , that
would be targeted and could help define HCC patients
at high risk for developing HCC after hepatectomy. The
potential mediators of PI-DR are of great interest and
warrant further study.
Materials and methods
Patients and clinical data
Archived, formalin-fixed and paraffin-embedded liver
specimens used in this study were obtained from the
Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
From January 1997 to December 2007, patients who
underwent hepatectomy and who were post-operatively
confirmed as hepatocellular carcinoma were recruited
for prospective follow-up. Informed consent was ob-
tained from each patient under a protocol approved by
the Hospital Research Ethics Committees. The following
tissue microarray included 138 pairs of intratumoral and
peritumoral liver tissues from the selected HCC patients.
Eighteen cases could not be analysed because of the loss
of the samples during the preparation of the tissue
microarray. The 120 remain study population consisted
of 108 men and 12 women with a mean age of 50.1 ±
11.9 years (range 11–89 years). Tumor size was based on
the largest dimension of the tumor specimen. Satellite
lesions were defined by the presence of 2 or more nod-
ules including intrahepatic metastases. Microvascular in-
vasion was determined by microscopic examination of
the resected specimen, whereas macrovascular invasion
was identified by macroscopic examination of specimen.
Tumor stage was determined according to the 2009 UICC
TNM (International Union Against Cancer, Tumor Node
Metastasis) classification system [30]. Tumor differenti-
ation was assessed according to Edmonson and Steiner
grading system. The severity of the inflammation at the
interface between portal tracts and the parenchyma was
assessed on the H&E stained section and graded accor-
ding to Knodell et al. [31]. Fibrosis was assessed sepa-
rately, as suggested by Desmet et al. [32]. The specimens
were divided into four groups according to the HAI score
for necroinflammation grade. The first group included bi-
opsies with HAI 0–4 (absent activity), the second group
biopsies with HAI 5–8 (mild activity), the third group bi-
opsies with HAI 9–12 (moderate activity) and the last
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specimens were also divided into three groups according
to the degree of fibrosis, which was staged with scores
ranging from 1 to 3, corresponding to: absence or mild fi-
brosis (stage 1), moderate or severe (bridging) fibrosis
(stage 2) and cirrhosis (stage 3).
Follow-up and detection of recurrence
All patients were followed regularly every 2–3 months
after surgery until study closure in July 2010 with serum
AFP/CA19-9 and abdominal ultrasonography. Progres-
sive elevation of serum AFP/CA19-9 levels and/or ultra-
sonographic detection of a new hepatic lesion prompted
hospitalization for confirmation of diagnosis and
appropriate management, including repeat resection,
radiofrequency ablation (RFA), transcatheter arterial
chemoembolization (TACE) or supportive therapy. Re-
currence was confirmed by contrast-enhanced imaging
studies according to standard guidelines for HCC [33].
Overall survival (OS) was defined as the interval be-
tween the dates of surgery and death while disease-free
survival (DFS) was defined as the interval between the
dates of surgery and recurrence. If recurrence was not
diagnosed, patients were censored on the date of death
or the last follow-up. Clinical follow-up was not dis-
closed to laboratory personnel until statistical analysis.
Tissue microarray (TMA) construction
Tissue microarray (TMA) construction was described in
previous reports [34]. Briefly, we constructed the tissue
microarray, containing of 120 pairs of intratumoral and
peritumoral liver specimens from the enrolled HCC pa-
tients. TMA slides with 120 pairs of intratumoral and
matched peritumoral samples were constructed. In brief,
all archival formalin-fixed and paraffin-embedded speci-
mens used in this study were freshly sectioned and
stained with haematoxylin and eosin (H & E). The H &
E-stained sections were carefully reviewed by two inde-
pendent pathologists without knowledge of the patients’
clinical characteristics and outcomes, and the represen-
tative regions of the intratumoral and peritumoral liver
tissues were defined for microarray, and the peritumoralTable 5 List of antibodies used
Antibody Source
CK7 Mouse monoclonal; Dako, Glostrup, Den
EpCAM Mouse monoclonal; Dako, Glostrup, Den
CD133 Rabbit monoclonal; Cell Signaling Technology, D
CD117 (c-kit) Rabbit polyclonal; Dako, Glostrup, Denm
OV6 Mouse monoclonal; R & D Systems, Emeryv
PCNA Mouse monoclonal; Cell Signaling Technology, D
CK7 cytokeratin 7, EpCAM epithelial cell adhesion molecule , CD133 cluster of differ
oval cell marker, PCNA proliferating cell nuclear antigen.tissues at the distance (15mm) from the tumor margin
were collected. Using a tissue arraying instrument
(Beecher Instruments, Sliver Spring, MD), each tissue
core with a diameter of 1.5 mm was punched from the
marked areas of intratumoral and peritumoral tissues
and re-embedded. TMAs containing the tissue cores
were then cut into five-micrometre sections for
IHC staining.
Immunohistochemical staining
Serial five-micrometre thick sections of tissue array
blocks were examined immunohistochemically using a
standard two-step method. Sections were de-paraffinized
and rehydrated, and endogenous peroxidase was
quenched with 3% peroxid (20 min). After antigen re-
trieval in 10mM sodium citrate buffer (pH 6.0) or Ethyl-
ene Diamine Tetraacetic Acid (EDTA,1 mmol/L, PH 8.0)
for 20 min at 95°C, the sections then were treated with
2% normal goat serum and incubated with primary anti-
bodies overnight at 4°C. After washing with phosphate-
buffered saline, sections were incubated with Two stept
anti-rabbit or anti-mouse reagent (HRP) (Antibody,
Diagnostica Inc, NY) at 37°C for an hour. 3,3′-Diamino-
benzidine tetrahydrochloride (DAB) was used as the
suitable substrate-chromogen and Mayer’s hematoxylin
counterstain was applied. Negative controls were treated
identically but with the primary antibody omitted. Infor-
mation on antibodies used and antigen-retrieval condi-
tions are summarized in Table 5.
Histopathologic and immunohistochemical evaluation
All slides of positive HPC markers (EpCAM, OV6, C-kit
and CD133) staining were observed and photographed
with an Olympus microscope (IX-70 OLYMPUS, Japan).
Three independent investigators examined the TMA
slides without related clinical information. Under 200×
magnification, images of positive representative fields
were captured. The density of immunostaining was mea-
sured using Image-Pro Plus Version 6.2 software (Media
Cybernetics Inc., Bethesda, MD), described previously as
an established method [4]. The integrated optical density
(IOD) in each image was measured, and the density ofDilution Antigen retrieval
mark 1:50 Citrate buffer, pH 6.0
mark 1:200 Citrate buffer, pH 6.0
anvers, MA 1:100 Citrate buffer, pH 6.0
ark 1:400 EDTA buffer, PH 8.0
ille, CA 1:40 EDTA buffer, PH 8.0
anvers, MA 1:4000 Citrate buffer, pH 6.0
entiation (CD)133, CD117 (c-kit) mast/stem cell growth factor receptor, OV6
Ye et al. Cell & Bioscience 2014, 4:50 Page 13 of 14
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image. For calculating HPC markers (e.g. EpCAM, OV6,
CD133 and c-kit) density, the cutoff for the definition of
subgroups was the median IOD to separate high HPC
markers’ expression (IOD >median) from low HPC
markers’ expression (IOD ≤median) in microarray tissue
samples.Evaluation of K7-DR and PI-DR
For quantification of the total area of ductular reaction
(DR), non-overlapping fields of the biopsy specimen
were photographed at 100× magnification after immuno-
histochemical staining for CK7. The extent of CK7-
immunoreactive ductular reaction was semiquantitatively
assessed and graded with some modification in a manner
analogous to the grading of interface hepatitis in the scor-
ing system of Ishak et al. [31]: In addition, proliferation
rate in DR was evaluated by calculating the proliferating
cell nuclear antigen(PCNA) labeling index as described in
our previous reports [21]. Specifically, 3 400× highpow-
ered fields within each section were randomly chosen and
captured. The same fields were captured in sequential ser-
ial sections stained with K7 for quantification of the num-
ber of reactive ductular cells (RDCs) in reactive ductules
[35]. The proliferation index of DR (PI-DR) was calculated
as ratio between the number of PCNA immunoreactive
nuclei and the total number of RDCs.Statistical analysis
Statistical analysis was performed using with SPSS 20.0
for Windows (SPSS Inc., Chicago, IL); Differences
between categorical variables were assessed by the
chi-square test or Fisher’s exact test, when necessary.
Pearson’s correlation coefficient was used to determine
correlations between continuous normally distributed
variables. The degree of association between non-
parametric or ordinal variables was assessed by using
Spearman nonparametric correlation. Kaplan-Meier ana-
lysis was used to determine the survival. Log-rank test
was used to compare patients’ survival between sub-
groups; Significant variables from the univariable ana-
lysis were entered in the multivariable analysis, which
was performed using the Cox-proportional hazards
model with forward stepwise selection. P < 0.05 was con-
sidered statistically significant.
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